Constellium Se
CSTM NYSE Secondary Smelting & Refining Of Nonferrous Metals Financials FY2022βFY2025
What Constellium Se does
No business description yet.
- Legal name
- CONSTELLIUM SE
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Feb 25, 2026
- Accession Β· CIK
- 0001563411-26-000057
0001563411
Revenue and margins
Constellium Se had $8.4B of revenue in fiscal 2025, up 15.2% on the year before.
Net income and earnings per share
From fiscal 2022 to 2025, diluted EPS grew β2.9% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $159M in fiscal 2025, 1.9% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Constellium Se returned $115M to shareholders in fiscal 2025, 72% of free cash flow. The diluted share count fell 4.1%.
Balance sheet
Cash, debt and the ratios that show how comfortably Constellium Se can carry it.
| Fiscal year end | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|
| Cash and short-term investments | $176M | $223M | $141M | $120M |
| Debt incl. finance leases | β | $2.0B | $1.9B | $2.0B |
| Debt / equity | β | 2.7x | 2.7x | 2.0x |
| Current ratio | β | 1.3x | 1.3x | 1.3x |
| Quick ratio | β | 0.5x | 0.5x | 0.5x |
| Total assets | β | $4.9B | $4.7B | $5.4B |
| Total liabilities | β | $4.2B | $4.0B | $4.4B |
| Shareholders' equity | $603M | $718M | $706M | $952M |
| Net debt (β = net cash) | β | $1.7B | $1.8B | $1.9B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|
| Net income is positive | β | β | β | β |
| Cash from operations is positive | β | β | β | β |
| Return on assets rose | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β |
| Debt fell relative to assets | β | β | β | β |
| Current ratio rose | β | β | β | β |
| Share count didn't rise | β | β | β | β |
| Gross margin rose | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β |
| F-score | β / 3 | β / 4 | 4 / 8 | 8 / 8 |
| Accruals ratio | β | β5.7% | β5.1% | β4.3% |
| Altman Z'' | β | β | β | β |
4 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | $8.5B | $7.8B | $7.3B | $8.4B |
| Research and development | $46.0M | $52.0M | $49.0M | $51.0M |
| Interest expense | $96.0M | $101M | $99.0M | $102M |
| Pretax income | $150M | $232M | $135M | $408M |
| Income tax | β$165M | $75.0M | $75.0M | $133M |
| Net income | $308M | $152M | $56.0M | $273M |
| Diluted EPS | $2.10 | $1.03 | $0.38 | $1.92 |
| Diluted shares | 0.15B | 0.15B | 0.15B | 0.14B |
| Cash flow | ||||
| Cash from operations | $365M | $432M | $301M | $489M |
| Capital expenditure | $289M | $366M | $413M | $330M |
| Free cash flow | $76.0M | $66.0M | β$112M | $159M |
| Depreciation and amortization | $290M | $300M | $304M | $330M |
| Stock-based compensation | $18.0M | $22.0M | $25.0M | $19.0M |
| Acquisitions | $0.0M | $0.0M | β$3.0M | $0.0M |
| Share buybacks | $0.0M | $0.0M | $79.0M | $115M |
| Dividends and buybacks | $0.0M | $0.0M | $79.0M | $115M |
| Balance sheet | ||||
| Cash and short-term investments | $176M | $223M | $141M | $120M |
| Total debt | β | $1.9B | $1.9B | $1.9B |
| Finance lease liabilities | β | $34.0M | $30.0M | $32.0M |
| Current assets | β | $2.0B | $1.8B | $2.3B |
| Current liabilities | β | $1.6B | $1.4B | $1.8B |
| Inventory | β | $1.2B | $1.2B | $1.4B |
| Property and equipment, net | β | $2.4B | $2.4B | $2.6B |
| Goodwill | β | $41.0M | $46.0M | $47.0M |
| Intangible assets | β | $104M | $97.0M | $88.0M |
| Total assets | β | $4.9B | $4.7B | $5.4B |
| Total liabilities | β | $4.2B | $4.0B | $4.4B |
| Shareholders' equity | $603M | $718M | $706M | $952M |
| Margins | ||||
| Net margin | 3.6% | 1.9% | 0.8% | 3.2% |
| FCF margin | 0.9% | 0.8% | β1.5% | 1.9% |
| Returns | ||||
| Return on equity | 51.1% | 23.0% | 7.9% | 32.9% |
| Return on assets | β | 3.1% | 1.2% | 5.4% |
| Return on tangible equity | 51.1% | 26.5% | 9.9% | 33.4% |
| Growth | ||||
| Revenue growth | β | β8.3% | β6.3% | 15.2% |
| Net income growth | β | β50.6% | β63.2% | 387.5% |
| EPS growth | β | β51.0% | β63.1% | 405.3% |
| FCF growth | β | β13.2% | β269.7% | β |
| Share count change | β | 1.0% | β0.3% | β4.1% |
| Financial health | ||||
| Debt / equity | β | 2.7x | 2.7x | 2.0x |
| Current ratio | β | 1.3x | 1.3x | 1.3x |
| Quick ratio | β | 0.5x | 0.5x | 0.5x |
| Capital allocation | ||||
| Capex / revenue | 3.4% | 4.7% | 5.6% | 3.9% |
| Stock comp / revenue | 0.2% | 0.3% | 0.3% | 0.2% |
| Payouts / FCF | 0.0% | 0.0% | β | 72.3% |
| Quality scores | ||||
| Piotroski F-score | β | β | 4.0 | 8.0 |
| Accruals ratio | β | β5.7% | β5.1% | β4.3% |
Source: SEC EDGAR XBRL filings (CIK 0001563411). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.